113 related articles for article (PubMed ID: 1927238)
1. The effects of a single oral dose of lorazepam and alprazolam on reaction times in young healthy volunteers.
Crombez G; Kupers R; Adriaensen H
Acta Anaesthesiol Belg; 1991; 42(2):79-84. PubMed ID: 1927238
[TBL] [Abstract][Full Text] [Related]
2. Psychomotor performance in healthy young adult volunteers receiving lormetazepam and placebo: a single-dose, randomized, double-blind, crossover trial.
Fabbrini M; Frittelli C; Bonanni E; Maestri M; Manca ML; Iudice A
Clin Ther; 2005 Jan; 27(1):78-83. PubMed ID: 15763608
[TBL] [Abstract][Full Text] [Related]
3. Differential effects of alprazolam on the baseline and fear-potentiated startle reflex in humans: a dose-response study.
Riba J; RodrÃguez-Fornells A; Urbano G; Morte A; Antonijoan R; Barbanoj MJ
Psychopharmacology (Berl); 2001 Oct; 157(4):358-67. PubMed ID: 11605094
[TBL] [Abstract][Full Text] [Related]
4. Anxiolytics and memory: a comparison of lorazepam and alprazolam.
Kumar R; Mac DS; Gabrielli WF; Goodwin DW
J Clin Psychiatry; 1987 Apr; 48(4):158-60. PubMed ID: 3558328
[TBL] [Abstract][Full Text] [Related]
5. Ritanserin versus lorazepam: a double-blind, cross-over study of reaction times in healthy volunteers.
Altamura AC; Colacurcio F; Marini S
Int J Clin Pharmacol Res; 1989; 9(3):197-201. PubMed ID: 2568349
[TBL] [Abstract][Full Text] [Related]
6. Unusual behavioral profile of alprazolam in squirrel monkeys.
Wettstein JG
J Pharmacol Exp Ther; 1990 Jun; 253(3):1070-6. PubMed ID: 2113579
[TBL] [Abstract][Full Text] [Related]
7. Different acute tolerance development to EEG, psychomotor performance and subjective assessment effects after two intermittent oral doses of alprazolam in healthy volunteers.
Barbanoj MJ; Urbano G; Antonijoan R; Ballester MR; Valle M
Neuropsychobiology; 2007; 55(3-4):203-12. PubMed ID: 17878744
[TBL] [Abstract][Full Text] [Related]
8. Sedation and memory: studies with a histamine H-1 receptor antagonist.
Turner C; Handford AD; Nicholson AN
J Psychopharmacol; 2006 Jul; 20(4):506-17. PubMed ID: 16401664
[TBL] [Abstract][Full Text] [Related]
9. Comparison of acute alprazolam (0.25, 0.50 and 1.0 mg) effects versus those of lorazepam 2 mg and placebo on memory in healthy volunteers using laboratory and telephone tests.
Vermeeren A; Jackson JL; Muntjewerff ND; Quint PJ; Harrison EM; O'Hanlon JF
Psychopharmacology (Berl); 1995 Mar; 118(1):1-9. PubMed ID: 7597114
[TBL] [Abstract][Full Text] [Related]
10. Comparison of behavioral effects after single and repeated administrations of four benzodiazepines in three mice behavioral models.
Bourin M; Hascoet M; Mansouri B; Colombel MC; Bradwejn J
J Psychiatry Neurosci; 1992 Jun; 17(2):72-7. PubMed ID: 1637802
[TBL] [Abstract][Full Text] [Related]
11. The pharmacokinetic and pharmacodynamic effects of SL65.1498, a GABA-A alpha2,3 selective agonist, in comparison with lorazepam in healthy volunteers.
de Haas SL; Franson KL; Schmitt JA; Cohen AF; Fau JB; Dubruc C; van Gerven JM
J Psychopharmacol; 2009 Aug; 23(6):625-32. PubMed ID: 18635696
[TBL] [Abstract][Full Text] [Related]
12. [Choice reaction time (CRT) in humans after administration of lorazepam].
Lombardi M; Cosi V
Boll Soc Ital Biol Sper; 1979 Jan; 55(2):171-6. PubMed ID: 17955645
[TBL] [Abstract][Full Text] [Related]
13. The acute and chronic performance effects of alprazolam and lorazepam in the elderly: relationship to duration of treatment and self-rated sedation.
Pomara N; Tun H; DaSilva D; Hernando R; Deptula D; Greenblatt DJ
Psychopharmacol Bull; 1998; 34(2):139-53. PubMed ID: 9640992
[TBL] [Abstract][Full Text] [Related]
14. Coadministration of nefazodone and benzodiazepines: I. Pharmacodynamic assessment.
Kroboth PD; Folan MM; Lush RM; Chaikin PC; Shukla UA; Barbhaiya R; Salazar DE
J Clin Psychopharmacol; 1995 Oct; 15(5):306-19. PubMed ID: 8830061
[TBL] [Abstract][Full Text] [Related]
15. A comparative pharmacokinetic and dynamic evaluation of alprazolam sustained-release, bromazepam, and lorazepam.
Busto UE; Kaplan HL; Wright CE; Gomez-Mancilla B; Zawertailo L; Greenblatt DJ; Sellers EM
J Clin Psychopharmacol; 2000 Dec; 20(6):628-35. PubMed ID: 11106134
[TBL] [Abstract][Full Text] [Related]
16. Flumazenil: US clinical pharmacology studies.
Dunton AW; Schwam E; Pitman V; McGrath J; Hendler J; Siegel J
Eur J Anaesthesiol Suppl; 1988; 2():81-95. PubMed ID: 2842144
[TBL] [Abstract][Full Text] [Related]
17. Effects of Oral Administration of Alprazolam and Lorazepam as Hypnotics on Cardiovascular Parameters in Hypertensive Patients.
Costa A; D'Angelo A; Ramusino MC; Perini G; Bosone D; Derosa G; Fogari R
J Clin Psychopharmacol; 2021 Mar-Apr 01; 41(2):191-195. PubMed ID: 33587402
[TBL] [Abstract][Full Text] [Related]
18. Pharmacodynamic and pharmacokinetic effects of TPA023, a GABA(A) alpha(2,3) subtype-selective agonist, compared to lorazepam and placebo in healthy volunteers.
de Haas SL; de Visser SJ; van der Post JP; de Smet M; Schoemaker RC; Rijnbeek B; Cohen AF; Vega JM; Agrawal NG; Goel TV; Simpson RC; Pearson LK; Li S; Hesney M; Murphy MG; van Gerven JM
J Psychopharmacol; 2007 Jun; 21(4):374-83. PubMed ID: 17092968
[TBL] [Abstract][Full Text] [Related]
19. Alprazolam and lorazepam single and multiple-dose effects on psychomotor skills and sleep.
Subhan Z; Harrison C; Hindmarch I
Eur J Clin Pharmacol; 1986; 29(6):709-12. PubMed ID: 3709614
[TBL] [Abstract][Full Text] [Related]
20. Tandospirone and alprazolam: comparison of behavioral effects and abuse liability in humans.
Evans SM; Troisi JR; Griffiths RR
J Pharmacol Exp Ther; 1994 Nov; 271(2):683-94. PubMed ID: 7965783
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
